Effectiveness of Mulligan Mobilization Technique and Core Stabilization Exercise With Knee Osteoarthritis

April 20, 2022 updated by: Meryem BUKE, Pamukkale University

Investigation of the Effectiveness of Mulligan Mobilization Technique and Core Stabilization Exercises in Female Patients With Knee Osteoarthritis: A Randomized Controlled Single-Blind Study.

Osteoarthritis (OA) is a chronic disease process characterized by degeneration and inflammation in the joint cartilage and subchondral bone, synovial fluid and joint capsule. One of the most affected joints in OA is the knee joint, and the incidence of OA increases with age.

Different treatment approaches are used in the treatment of osteoarthritis. The aim of the study is to examine the effectiveness of Mulligan technique and core exercises applied to female patients with knee osteoarthritis. In addition, the investigators did not find any study examining the effect of Mulligan technique on static balance in the treatment of OA. This is the secondary aim of the study.

Study Overview

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Denizli, Turkey, 20070
        • Pamukkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Being diagnosed with knee osteoarthritis
  • To be in the age range of 40-70
  • No lower extremity surgery in the last 6 months.
  • Agree to participate in the study

Exclusion Criteria:

  • Having had hip-knee replacement surgery
  • Surgery planned in the last 6 months
  • Having received physical therapy in the last 6 months
  • Having uncontrollable hypertension and cardiac problems
  • Having been diagnosed with rheumatoid arthritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mulligan mobilization group
Painless movement
Mulligan mobilization technique will be apply.
Experimental: Core stabilization group
Abdominal drawing-in maneuver
Core stabilization technique will be apply.
Active Comparator: conventional therapy group
Ultrasound TENS Hotpack
Conventional therapy exercise will be apply.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain assessment
Time Frame: 10 minutes
Visual Analog Scale: This scale consists of a straight line with the end points defining extreme limits such as 'no pain at all', which is 0 cm, and 'pain as bad as it could be', which is 10cm.
10 minutes
Range of motion assessment
Time Frame: 10 minutes
Goniometric measurement
10 minutes
muscle strength assessment
Time Frame: 10 minutes
by handheld device (Commander Powertrack II brand)
10 minutes
functional level assessment
Time Frame: 5 minutes
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
5 minutes
aerobic endurance assessment
Time Frame: 6 minutes
6 minute walk test
6 minutes
balance assessment
Time Frame: 5 minutes
Stand on one leg test
5 minutes
Timed Up& Go Test
Time Frame: 5 minutes
Timed Up& Go Test
5 minutes
assessment of quality of life survey
Time Frame: 5 minutes
Nottingham Health Profile
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 14, 2020

Primary Completion (Actual)

February 1, 2022

Study Completion (Actual)

April 20, 2022

Study Registration Dates

First Submitted

August 27, 2020

First Submitted That Met QC Criteria

September 4, 2020

First Posted (Actual)

September 7, 2020

Study Record Updates

Last Update Posted (Actual)

April 21, 2022

Last Update Submitted That Met QC Criteria

April 20, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 60116787-020/48052

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on Mulligan mobilization

3
Subscribe